Renaissance Technologies
NMTC icon

Renaissance Technologies’s NeuroOne Medical Technologies NMTC Stock Holding History

Renaissance Technologies’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-70,861
Closed -$215K – 3434
2026
Q2 		$215K Sell
70,861
-38,380
-35% -$157K ﹤0.01% 2867
2026
Q1 		$509K Sell
109,241
-17,930
-14% -$86.1K ﹤0.01% 2592
2025
Q4 		$578K Buy
127,171
+11,738
+10% +$53.5K ﹤0.01% 2516
2025
Q3 		$615K Buy
115,433
+37,283
+48% +$183K ﹤0.01% 2706
2025
Q2 		$318K Buy
+78,150
New +$289K ﹤0.01% 3022

Other funds holding NMTC

Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies's NMTC Position: Q3 2026 in Review

Renaissance Technologies sold out of NeuroOne Medical Technologies (NMTC) in Q3 2026, closing a stake of 70,861 shares — an estimated $215K sold.

Renaissance Technologies first reported a position in NMTC in Q2 2025 and held it in 5 quarters. The position peaked at $615K in Q3 2025. 18 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • Renaissance Technologies reported no remaining NeuroOne Medical Technologies position as of Q3 2026 after selling out during the quarter.
  • Renaissance Technologies sold 70,861 NeuroOne Medical Technologies shares in Q3 2026, an estimated $215K.
  • Renaissance Technologies first reported a position in NeuroOne Medical Technologies in Q2 2025 and held it in 5 quarters.
  • Renaissance Technologies's NeuroOne Medical Technologies position peaked at $615K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.